Neurocode at CTAD 2026

Nov 16–19, 2026 Boston, MA ~1.7k attendees Website

Neurocode takes part in 1 session at CTAD 2026 in Boston. Its program reports the clinical verification of the Lumipulse p-tau217 to amyloid-beta 42 ratio assay in its laboratory.

OrganizationCTAD 2026 Attendance
Neurocode
Bellingham, Washington
◇Silver Sponsor
neurocode.com
Biomarker & diagnostics companiesSilver Sponsor
CAP/CLIA-certified neurology lab offering blood p-tau217 tests for Alzheimer's and antibody tests for autoimmune neurological diseases.
Poster
Wed Nov 18
7:15am–5:30pm

Explore the full CTAD 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Boston. Leave your work email and we’ll be in touch.

Privacy

Download the full CTAD 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Neurocode

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the CTAD Conference. Organization details are derived from CTAD’s published program, poster list and sponsor page. Submit a correction